Ifosfamide (DrugBank: Ifosfamide)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
34 | 神経線維腫症 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00304083 (ClinicalTrials.gov) | December 2005 | 15/3/2006 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors | Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors | Neurofibromatosis Type 1;Sarcoma | Biological: filgrastim;Drug: doxorubicin hydrochloride;Drug: etoposide;Drug: ifosfamide;Procedure: conventional surgery;Radiation: radiation therapy | Sarcoma Alliance for Research through Collaboration | National Cancer Institute (NCI) | Completed | N/A | N/A | All | 48 | Phase 2 | United States;Canada |